CUPISCO

Name No. For Patients with Purpose
CUPISCO CTRIAL-IE 18-29

Multiple types of cancer.

This study will evaluate the efficacy and safety of targeted therapy or cancer immunotherapy guided by genomic profiling versus platinum-based chemotherapy


MK7339-002 / LYNK-002

Name No. For Patients with Purpose
MK7339-002 / LYNK-002 CTRIAL-IE 19-27

Multiple types of cancer

This study will evaluate the efficacy and safety of olaparib monotherapy in participants with multiple types of advanced cancer (unresectable and/or metastatic).


Add-Asprin

Name No. For Patients with Purpose
Add-Asprin 16-19

Non-metastatic breast, colorectal, gastro-oesophagal or prostate cancer which can be treated and potentially cured.

The purpose of this study is to evaluate the the effects of aspirin on disease recurrence and survival in patients who have had primary curative therapy for common non-metastatic solid tumours.


LOXO 101

Name No. For Patients with Purpose
LOXO 101 15-42

NTRK fusion-positive breast cancer

The purpose of the trial is to determine the overall response rate following treatment with LOXO-101.